Hemolytic Uremic Syndrome Following Holmium Laser Enucleation of the Prostate: A Case Report
Wojciech Krajewski, Lukasz Nowak, Patryk Patrzałek, Wojciech Tomczak, Joanna Chorbinska, Jan Laszkiewicz, Bartosz Malkiewicz, Tomasz Szydelko

TL;DR
A rare case of hemolytic uremic syndrome occurred after prostate surgery, requiring intensive care and leading to eventual kidney recovery.
Contribution
This case report highlights a rare complication of HoLEP surgery and emphasizes the need for early recognition and multidisciplinary care.
Findings
A 71-year-old male developed HUS following HoLEP surgery.
The patient required intensive care and renal replacement therapy.
Renal function showed progressive recovery after a month-long hospitalization.
Abstract
Holmium laser enucleation of the prostate (HoLEP) is a widely used surgical treatment for benign prostatic hyperplasia (BPH), and it is associated with a low incidence of severe complications. We report a rare case of hemolytic uremic syndrome (HUS) following HoLEP in a 71-year-old male. Shortly after the surgery, the patient developed altered consciousness, jaundice, and multiorgan failure, necessitating intensive care and renal replacement therapy. HUS was identified as the underlying cause. After a month-long hospitalization, the patient showed progressive renal recovery. This report underscores the importance of early recognition, multidisciplinary management, and close follow-up in achieving favorable outcomes in rare post-HoLEP complications.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsUrinary Bladder and Prostate Research · Heme Oxygenase-1 and Carbon Monoxide · Vascular anomalies and interventions
